Iberia Pharmaceuticals, a known name in science-backed skincare, is set to open its
state-of-the-art manufacturing and research facility in Jhajjar, Haryana, marking a significant step in its expansion across India. Spanning 60,000 sq. ft., the next-generation unit will become operational by mid-2026, representing an investment of ₹70 crore. The initiative aligns with the government’s ‘Make-in-India’ movement, reinforcing Iberia’s commitment to manufacturing excellence and national development.
Engineered for Excellence and Scale
Equipped with best-in-class control systems and advanced equipment, the new facility will ensure large-scale commercial manufacturing without compromising international standards of quality, compliance, or environmental sustainability. Iberia aims to produce more than 12 million units annually, focused on dermatology, wellness, and chronic care, catering to both Indian and global markets. A skilled team will lead operations to ensure smooth execution while maintaining a strong focus on cost-effective, high-quality, and responsible skincare solutions.
Driving Innovation Through Research and Nanotechnology
The facility will house cutting-edge R&D laboratories to track market trends, develop innovative formulations, and continuously refine existing products. This research-led approach underpins Iberia’s philosophy of offering personalized, effective, and science-driven skincare. Building on its core strengths, Iberia continues to focus on nanotechnology-based skincare and therapeutic solutions that are vegan, high-performance, and pharmaceutical-grade. These solutions are designed to address diverse consumer needs in both dermatology and holistic wellness.
Leaders Speak
“This new plant marks a major milestone in our growth journey,” said Nitin Jain, Founder of Iberia Pharmaceuticals. “By bringing global manufacturing quality to India, we are building trust, capacity, and a future where healthcare meets world-class standards. This facility is one of several strategic initiatives we are implementing to support rapid growth. We proudly support the Government of India’s vision of expanding access to high-quality, affordable healthcare solutions,” Jain added.
Co-founder Saurav Ojha said, “At Iberia Pharmaceuticals, our purpose is clear—we want to deliver healthcare solutions that are precise, safe, and responsible. Our new advanced manufacturing and research facility stands as a symbol of that commitment. Through nanotechnology and deep scientific research, we are setting new benchmarks in dermatological excellence.”
Trusted Brands for Professionals and Consumers
Iberia Pharmaceuticals continues to bring clinically tested, globally trusted brands to India. These solutions cater to both consumers and healthcare professionals. Its portfolio includes respected names like Sesderma, Mediderma, Dermpix, Noreva, and Metacare. These brands cater to dermatologists, wellness clinics, and individuals seeking reliable, effective skincare solutions.
